Gene · 23521
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia-mimicked mitochondrial stress triggers APOBEC3A-mediated DNA damage via non-canonical innate immune activation. | NAR Mol Med | 2026 | 41737027 | PubTator, text mining | PubMed |
| PFKM governs metabolic shifts throughout skeletal muscle differentiation. | Nat Metab | 2026 | 41735679 | PubTator, text mining | PubMed |
| Advances in the study of nucleolar small RNAs in colorectal cancer. | iScience | 2026 | 41732269 | PubTator, text mining | PubMed |
| Alpha-synuclein overexpression triggers divergent cellular responses and post-translational modifications in SH-SY5Y and ReNcell VM models. | Cell Mol Life Sci | 2026 | 41721127 | PubTator, text mining | PubMed |
| Biomaterial Screening Identifies Enhanced Osteogenic and Angiogenic Potential of Mn-Doped Calcium Phosphate Coatings. | ACS Biomater Sci Eng | 2026 | 41720464 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Mfsd2a is important for maintaining epidermal homeostasis. | Proc Natl Acad Sci U S A | 2026 | 41712644 | PubTator, text mining | PubMed |
| Chemomechanical remodeling of glucocorticoid-sensitive fibroblasts for multimodal synergistic therapy of skin fibrosis. | Cell Rep Med | 2026 | 41707648 | PubTator, text mining | PubMed |
| Lactate metabolism-driven tumor heterogeneity and molecular signatures in intrahepatic cholangiocarcinoma. | World J Gastroenterol | 2026 | 41694488 | PubTator, text mining | PubMed |
| Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. | PLoS One | 2026 | 41576104 | PubTator, text mining | PubMed |
| Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model. | Invest Ophthalmol Vis Sci | 2026 | 41556586 | PubTator, text mining | PubMed |
| Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. | ASPET Discov | 2025 | 42422326 | PubTator, text mining | PubMed |
| Validation of Housekeeping Genes for Normalizing RNA Expression in Real-Time PCR in Tuberculomas and Peripheral Blood Mononuclear Cells for Pulmonary Tuberculosis Patients. | Int J Mol Sci | 2025 | 41303702 | PubTator, text mining | PubMed |
| RNA binding of GAPDH controls transcript stability and protein translation in acute myeloid leukemia. | RNA Biol | 2025 | 41175344 | PubTator, text mining | PubMed |
| The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state. | Nucleic Acids Res | 2025 | 40842241 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up. | EBioMedicine | 2025 | 40840166 | PubTator, text mining | PubMed |
| Genome-wide in vivo and ex vivo mapping of R-loops using engineered N-terminal hybrid-binding domain of RNase H3 (enDR3). | Nucleic Acids Res | 2025 | 40823807 | PubTator, text mining | PubMed |
| Effects of diamond nanoparticle surface composition and the sp3/sp2 carbon ratio on tumor proangiogenic potential in vitro. | Sci Rep | 2025 | 40804455 | PubTator, text mining | PubMed |
| Selection of Stable Reference Genes for Gene Expression Studies in Activated and Non-Activated PBMCs Under Normoxic and Hypoxic Conditions. | Int J Mol Sci | 2025 | 40725038 | PubTator, text mining | PubMed |
| Correction to: Rpl13a snoRNAs U34 and U35a: New Targets for Sickle Cell Disease Complications. | Circ Res | 2025 | 40674452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/papers?page=2